Equitable Holdings Inc. Sells 9,433 Shares of UnitedHealth Group Incorporated $UNH

Equitable Holdings Inc. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,289 shares of the healthcare conglomerate's stock after selling 9,433 shares during the quarter. Equitable Holdings Inc.'s holdings in UnitedHealth Group were worth $13,420,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. MASTERINVEST Kapitalanlage GmbH raised its position in shares of UnitedHealth Group by 22.2% during the 2nd quarter. MASTERINVEST Kapitalanlage GmbH now owns 13,927 shares of the healthcare conglomerate's stock valued at $5,788,000 after buying an additional 2,527 shares in the last quarter. Jacobs Equity LLC raised its position in UnitedHealth Group by 22.6% during the second quarter. Jacobs Equity LLC now owns 2,443 shares of the healthcare conglomerate's stock valued at $1,015,000 after purchasing an additional 450 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth about $1,973,000. Transamerica Financial Advisors LLC raised its holdings in shares of UnitedHealth Group by 2.7% during the 2nd quarter. Transamerica Financial Advisors LLC now owns 6,539 shares of the healthcare conglomerate's stock valued at $2,718,000 after buying an additional 175 shares in the last quarter. Finally, Corient Private Wealth LP bought a new position in UnitedHealth Group during the second quarter valued at approximately $245,516,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the company's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company's stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $394.57 on Friday. The business's 50 day moving average price is $413.42 and its 200-day moving average price is $359.88. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The firm has a market cap of $354.16 billion, a P/E ratio of 25.39, a P/E/G ratio of 1.39 and a beta of 0.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the previous year, the firm earned $4.08 EPS. The company's quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio is currently 59.72%.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Erste Group Bank lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday. Barclays raised their price objective on UnitedHealth Group from $429.00 to $441.00 and gave the company an "overweight" rating in a research note on Monday, July 20th. Oppenheimer increased their target price on UnitedHealth Group from $420.00 to $500.00 and gave the company an "outperform" rating in a report on Friday, July 17th. Piper Sandler set a $477.00 price objective on UnitedHealth Group in a research report on Thursday, July 16th. Finally, Mizuho lifted their target price on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an "outperform" rating in a research note on Monday, July 20th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $456.56.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source